| Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center |
NCT00659750: To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402) |
|
|
| Completed | 3 | 418 | US | Ciclesonide, Placebo | AstraZeneca | Rhinitis, Allergic, Perennial | 05/04 | 04/05 | | |
NCT00659841: To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401) |
|
|
| Completed | 3 | 302 | US | Ciclesonide, Placebo | AstraZeneca | Rhinitis, Allergic, Seasonal, Hay Fever | 12/04 | 02/05 | | |
NCT00659594: Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406) |
|
|
| Completed | 3 | 500 | Canada | Ciclesonide, Placebo | AstraZeneca | Rhinitis, Allergic, Seasonal, Hay Fever | 02/05 | 09/05 | | |
NCT00163501: Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404) |
|
|
| Completed | 3 | 600 | US | Ciclesonide | AstraZeneca | Perennial Allergic Rhinitis, Allergic Rhinitis, Hay Fever | 04/05 | 04/05 | | |
NCT00658918: To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405) |
|
|
| Completed | 3 | 120 | US | Ciclesonide nasal, Placebo | AstraZeneca | Rhinitis, Allergic, Perennial, Hay Fever | 04/05 | 11/05 | | |
NCT00659048: Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408) |
|
|
| Completed | 3 | 106 | US | Ciclesonide, Placebo | AstraZeneca | Rhinitis, Allergic, Perennial | 04/05 | 12/05 | | |
NCT00659503: Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407) |
|
|
| Completed | 3 | 420 | Canada | Ciclesonide, Placebo | AstraZeneca | Rhinitis, Allergic, Seasonal, Hay Fever | 04/05 | 11/05 | | |
NCT00163514: Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403) |
|
|
| Completed | 3 | 636 | US, Canada | Ciclesonide | AstraZeneca | Perennial Allergic Rhinitis, Allergic Rhinitis, Hay Fever | 07/05 | 07/05 | | |
NCT00163488: Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409) |
|
|
| Completed | 3 | 106 | US | Ciclesonide | AstraZeneca | Perennial Allergic Rhinitis, Allergic Rhinitis, Hay Fever | 08/05 | 08/05 | | |
NCT00261287: Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416) |
|
|
| Completed | 3 | 102 | US | Ciclesonide | AstraZeneca | Hay Fever, Perennial Allergic Rhinitis | 06/06 | 06/06 | | |
NCT00305487: Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417) |
|
|
| Completed | 3 | 660 | US | Ciclesonide nasal spray | AstraZeneca | Hay Fever, Seasonal Allergic Rhinitis | 10/06 | 10/06 | | |
NCT00384475: A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413) |
|
|
| Completed | 3 | 500 | Canada | Ciclesonide Nasal Spray | AstraZeneca | Rhinitis, Allergic, Seasonal, Hay Fever | 01/07 | 01/07 | | |
NCT00790023: Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis |
|
|
| Completed | 3 | 707 | US | 80 mcg Ciclesonide, 160 mcg Ciclesonide, Placebo | Sunovion | Seasonal Allergic Rhinitis | 02/09 | 02/09 | | |
NCT00953147: A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older |
|
|
| Completed | 3 | 1110 | US | Ciclesonide HFA 80 mcg, Ciclesonide HFA 160 mcg, Placebo | Sunovion | Allergic Rhinitis, Perennial Allergic Rhinitis | 01/10 | 05/10 | | |
NCT01010971: Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older |
|
|
| Completed | 3 | 671 | US | Ciclesonide HFA 160 μg, Ciclesonide HFA 80 μg, Placebo | Sunovion | Seasonal Allergic Rhinitis | 02/10 | 02/10 | | |
NCT01033825: Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis |
|
|
| Completed | 3 | 310 | US | Ciclesonide HFA Nasal Aerosol 320 mcg, Ciclesonide HFA Nasal Aerosol 160 mcg, HFA Nasal Aerosol placebo, Ciclesonide Aqueous Nasal Spray 200 mcg, Omnaris, AQ Nasal Spray Placebo, Placebo plus Dexamethasone HFA, Decadron, Placebo AQ plus Dexamethasone 6 mg | Sunovion | Perennial Allergic Rhinitis | 05/10 | 05/10 | | |
NCT01067105: A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older |
|
|
| Completed | 3 | 824 | US | ciclesonide HFA 160 μg | Sunovion | Perennial Allergic Rhinitis | 11/10 | 11/10 | | |
NCT01287364: Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis |
|
|
| Completed | 3 | 185 | US | ciclesonide hydrofluoroalkane (HFA) nasal aerosol, mometasone nasal inhalation, Nasonex® | Sunovion | Perennial Allergic Rhinitis | 04/11 | 04/11 | | |
NCT02273817: A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnarisâ„¢ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis |
|
|
| Completed | 3 | 580 | US | Ciclesonide nasal spray, 50 μg per actuation. | Apotex Inc. | Seasonal Allergic Rhinitis | 08/11 | 08/11 | | |
NCT01378429: Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis |
|
|
| Completed | 3 | 89 | US | ciclesonide nasal aerosol, Placebo | Sunovion | Perennial Allergic Rhinitis, PAR | 11/11 | 11/11 | | |
NCT01401465: Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray |
|
|
| Completed | 3 | 327 | US | ciclesonide, mometasone | Sunovion | Perennial Allergic Rhinitis | 11/11 | 11/11 | | |
NCT01451541: A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR). |
|
|
| Completed | 3 | 848 | US | Ciclesonide nasal aerosol 37 mcg, ciclesonide nasal aerosol 74 mcg, Placebo | Sunovion | Perennial Allergic Rhinitis, PAR | 12/12 | 12/12 | | |
NCT01458275: A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR) |
|
|
| Completed | 3 | 847 | US | Ciclesonide nasal aerosol 37 mcg, ciclesonide nasal aerosol 74 mcg, Placebo | Sunovion | Seasonal Allergic Rhinitis | 03/13 | 03/13 | | |
NCT02155881: Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia |
|
|
| Completed | 3 | 80 | RoW | Ciclesonide, Omnaris®, Ciclesonide Placebo | AstraZeneca | Seasonal Allergic Rhinitis | 10/14 | 11/14 | | |
